تدريب Shadowing: Congestive Heart Failure | Clinical Medicine - تعلم التحدث بالإنجليزية عبر الفيديو

اختر وضع التدريب

كل وضع يفتح غرفة تدريب بملء الشاشة.

827 جمل

إذا كانت الجمل قصيرة أو طويلة جدًا، انقر على Edit لتعديلها.

what's up ninja nerds in this video today

we're going to be talking about heart failure this is going to be again within our clinical medicine section

if you guys really like this video

and this helps you please support us by hitting

that like button comment down the comment section and most importantly subscribe also

if you guys want some great notes some great illustrations to

follow along with go down the description box below check out our link it'll take you to our website.

We have a lot of great stuff there.

Also, if you guys are interested,

we are actually developing a course for the USMLE Step 2 and pants that'll cover all of this in great detail.

Go check that out as well.

And check out the merch.

We got some great stuff.

Please go to our website.

Check out all this stuff.

Get yourself some swag.

All right, let's start talking a little bit about CHF or heart failure, congestive heart failure, many different terminologies there.

When we talk about heart failure, the first thing I want to talk about is the pathophysiology behind it.

And really, there's a couple different types of heart failure believe it

or not there's left heart failure right heart failure

and this weird one called high output failure we're going to talk first about left heart failure

which is going to be by far the most common type of heart failure now we talk about left heart failure

we want to think about two different types or subtypes

if you will of left heart failure this is what's called systolic heart failure

and diastolic heart failure now what would cause

this patient who has a normal heart to start diverting its way into developing systolic heart failure.

The primary reason why this would develop is a patient would have a reduction in their contractility.

So the contractility of the left ventricular myocardium is going down.

So there's a drop in the contractility.

So then you have to ask yourself the question, what is causing this left ventricular myocardium to not contract?

What are the disease processes which would lead to this?

So here, we're going to say that this myocardium here, this left ventricular myocardium is damaged in some way,

shape, or form, and the contractility here is knocked down.

What's some causes?

One of the most common causes here by far is going to be a myocardial infarction.

If a patient had an MI, it's going to cause fibrosis of that tissue.

Do you lose contractility there?

That's one way.

Another one, believe it or not, is cardiomyopathies.

You know which one particularly is very, very commonly associated with this one? it's called dilated cardiomyopathy

because what happens is that the actual ventricles get really really thin

and very weak that's another one where the contractility goes down another one could be myocarditis

but it's relatively uncommon but we'll put that one down as well

so another one could be myocarditis so inflammation of the myocardium

but all of these things would be stimulatory factors

that could lead to systolic heart failure where the contractility is just not good.

If the contractility of the heart is not good,

particularly the left ventricle, can it push blood out of the left ventricle and into the aorta very well?

No. And so this is where the issue occurs, is that the patient has a hard time being able to pump blood out of the heart.

So it's a problem with forward flow.

There's a very important kind of like formula.

We're not going to go crazy into it, but it helps us determine something called the left ventricular ejection fraction.

And this is a very important terminology.

So in this person who has systolic heart failure, sometimes what happens is, is as you drop the contractility, as you drop the contractility,

you drop what's called the left ventricular ejection fraction, which is basically the amount of blood that you're able to pump out of the heart, right?

And so when this happens, a decrease in left, the contractility, when that happens, that goes down, you drop your left ventricular ejection fraction

and now it's hard being able to get blood out of the heart when

that happens what we do is we have a very specific

terminology whenever the patient has a reduced left ventricular ejection fraction particularly particularly

when it's less than 40 percent you know we call

that we call that heart failure with a reduced ejection fraction we call this HEFREF.

And that's usually when it's less than 40%.

So when the left ventricular ejection fraction is less than 40%, we call that HEFREF, which is another way of describing systolic heart failure.

But the whole point here that I want you to understand is contractility is down.

The amount of blood getting out of the heart is down.

So what is that called when the volume of blood

that you're supposed to be pumping out of the heart in one minute goes down?

That's cardiac output.

So, in these patients, they will start to experience a drop in their cardiac output, which we're going to abbreviate CO.

And that's the big highlighting factor here for systolic heart failure or HEFREF, heart failure with a reduced ejection fraction.

Their cause is drop in contractility due to these diseases.

Now, when we come over here to the other flavor of left heart failure, diastolic heart failure, this is another really, really common one.

The problem here is something different in the sense that it is really hard to get blood out of the heart.

And there's a couple ways that blood leaves the heart, right?

So we call that like stroke volume, the amount of blood that you're kind of getting out of the heart in one heartbeat.

That's dependent upon preload, contractility.

And what's the last one?

Afterload.

When the afterload is crazy high in these patients, it's hard for them to get blood out of the heart.

And that's usually the problem here, is that these patients develop a massive increase in their afterload.

What are diseases that would really kind of increase the afterload and cause these particular types of problems?

Chronic hypertension.

Can't say how common that particular etiology is.

That is probably going to be by far one of the most common causes.

So this would be a chronic hypertension.

We'll put chronic here.

What's another one? you know there's a valve right here, right?

There's a valve right here called the aortic valve, the aortic semilunar valve.

What if that valve is super, super stenotic?

And because it's crazy, crazy stenotic, it's almost hard.

It's kind of obstructing the forward flow.

That would also cause a lot of afterload.

Aortic stenosis is another really common cause here.

So another disease would be called aortic stenosis.

This is another very, very common cause for an increase an afterload it's basically anything

that's going to make

it harder for the blood to get out of the left

ventricle these two things by far are going to be the most common thing

that will cause diastolic heart failure now in systolic heart failure what do you notice about the ventricle

100

super dilated right so let's actually write that over here so this is a very

101

dilated enlarged ventricle what you're going to notice here is

102

that this is super hypertrophied this ventricle is very hypertrophied

103

so you have what's called hypertrophy it's a very thick

104

and large left ventricle we call that left ventricular hypertrophy

105

or sometimes abbreviated LVH now the reason why is think about this

106

if the pressure in the actual aorta is so high

107

that you have to overcome it what what's the one way

108

that you can do that get stronger and thicken up the left ventricle.

109

But when you do that, when you thicken up this left ventricle and you make it to where you're actually able to generate higher stroke volumes,

110

the problem is now is that you decrease the actual space of the left ventricle.

111

And now my problem is that I can't get the deadened blood into the left ventricle.

112

I can't fill it properly.

113

And so this issue is a filling issue.

114

This was a forward flow issue.

115

So what do I notice here in this particular disease process?

116

The problem with diastolic heart failure is that they have a reduction in their filling process.

117

So there's a decrease in their left ventricular filling.

118

And because I can't fill the ventricles very well, that's going to cause a problem.

119

Now here's the thing.

120

Their left ventricular ejection fraction is completely fine.

121

It's usually completely preserved.

122

So this filling process won't affect their ejection fraction.

123

So their left ventricular ejection fraction is usually what we refer to in this case as normal.

124

Or let's use the term preserved.

125

And so that's where we get this term a heart failure with a lowercase p preserved ejection fraction,

126

where if we were to give it a particular number, it's at least greater than 40%.

127

So in these patient populations who have diastolic heart failure, their filling is reduced because their ventricles super,

128

super hypertrophied that causes their left ventricular ejection fraction to be preserved.

129

And they have what's called a half -pef.

130

But here's the question.

131

This has a low cardiac output because of low contractility.

132

This will also have a low cardiac output.

133

Do you guys know why?

134

Why this won't have a low cardiac output?

135

This will have a low cardiac output because, again, think about your physiology, guys.

136

It's very, very important to understand physiology here.

137

If I have a decreased filling, I'm not going to load my ventricle very well.

138

So my preload's going to drop.

139

If my preload drops, what happens to my stroke volume?

140

That goes down.

141

If stroke volume goes down, what happens to my cardiac output?

142

That goes down.

143

So both of these patients will have a low cardiac output,

144

but the primary difference here is that this is a preserved EF because they have no problem with their ejection fraction, no contractility problem.

145

This one has a reduced ejection fraction because they have a contractility problem.

146

Dilated ventricle, hypertrophied ventricle, super high yield, can't forget these things.

147

Understanding the causes of afterload, understand the cause of this contractility problem.

148

Okay, now we get into something that I think is really, really important and I think can often be overlooked.

149

When patients develop heart failure because of these issues, it can continue to get worse.

150

and worse and worse if not treated.

151

Let me explain why.

152

When cardiac output goes down, this is gonna go back a little bit to your physiology here.

153

When cardiac output goes down, what we know is there's always that formula.

154

Do you guys remember the formula for blood pressure?

155

The formula for blood pressure is you have this one here.

156

that blood pressure is equal to cardiac output times systemic vascular resistance.

157

In patients who have heart failure, what's the problem here?

158

Their cardiac output drops.

159

And then if you were to say keeping this normal or constant, what would happen to their blood pressure?

160

That would also drop.

161

So then what's the general compensatory mechanism that our body tries to create?

162

We'll do this in pink.

163

SVR has to go up.

164

And so this is usually what ends up happening to the body,

165

is the body creates this weird mechanism to try to increase your systemic vascular resistance

166

which causes a lot of problems let's see what that looks like

167

so the reason why you may be like zach

168

i really don't want to know this this is kind of like foundational stuff it's very helpful for your

169

pharmacology and understanding i promise

170

so here cardiac output's low normally what this will do is a couple different things

171

you know there's uh those baroreceptors and baroreceptors are located in like your carotids, like right at the bifurcation or at the aorta,

172

and they sense changes in cardiac output and blood pressure.

173

And so what happens is you're going to stimulate these things called baroreceptors,

174

and they're going to go and they're going to activate your sympathetic nervous system.

175

When your sympathetic nervous system becomes crazy activated, it's then going to jack up all your epinephrine and norepinephrine release.

176

So then what you're going to see is you're going to see a lot of epinephrine

177

and you're going to see a lot of norepinephrine increasing.

178

Why is that a problem?

179

Well, the reason why that's a problem is, is that these little chemicals here,

180

they love to go to the heart and to your vessels and cause some problems.

181

They go to the heart and they say, hey, why don't you speed up the heart rate?

182

Because if you speed up the heart rate, that'll increase the stroke volume, hopefully increase the critic output.

183

But it's not good for a patient's heart rate to be super high,

184

but that's one of the potential compensations is you're going to increase the patient's heart rate oops sorry guys

185

you're going to increase the heart rate and again this is

186

because it acts on what's called beta 1 receptors

187

this is going to become helpful

188

i promise the other thing is it acts on other types of receptors like alpha 1 receptors on your vasculature

189

and causes it to constrict and if you constrict these vessels what happens to the diameter of them they get smaller

190

What happens to the resistance?

191

It goes up.

192

So my SVR will go up.

193

And if that happens on the artery side, what's that going to do to my afterload?

194

It's going to go up.

195

And so it increases the afterload.

196

Now you're like, that sounds like a terrible thing.

197

It is terrible.

198

Because think about this.

199

If a patient has diastolic heart failure and you increase their afterload, what are you going to do?

200

You're going to worsen their diastolic heart failure because now if their afterload is high, what does their body try to do to compensate?

201

It hypertrophies and it's going to worsen their already present heart failure.

202

So this is going to be, it's going to trigger hypertrophy.

203

And guess what that's going to do?

204

That's going to worsen their heart failure and they're going to get sicker and their heart failure is going to get worse.

205

The other thing it's going to do is it's going to constrict the veins

206

because there's alpha -1 receptors on both the arteries and there's alpha one receptors on both the veins.

207

So it's going to squeeze the veins and try to push a lot of blood back to the heart.

208

And that's going to try to increase the preload.

209

But then if you increase the preload, now the ventricles have to dilate to accommodate for that volume.

210

And if the ventricle dilates, what does that sound like?

211

Systolic heart failure.

212

So it's going to worsen the patient's systolic heart failure.

213

So this is why it sounds like

214

These things are kind of like a good mechanism to try to increase your SVR.

215

That's what it's trying to do, is increase the SVR to increase your blood pressure, right?

216

But unfortunately, it worsens the patient's heart failure and their heart rate.

217

Another thing, if that wasn't enough, is this cardiac output is going to stimulate these like weird cells in the kidney called juxtaglomerular cells.

218

And these juxtaglomerular cells are very sensitive to blood pressure.

219

And what they'll do is they'll release a molecule called, you guys already know this, right?

220

Renin.

221

Alright, so it's going to release a molecule called renin.

222

Now, renin will then do what?

223

It'll then lead to the formation of angiotensin 1.

224

Angiotensin 1 will then lead to the formation of angiotensin 2.

225

What's the enzyme that stimulates that process?

226

ACE, don't forget that.

227

Angiotensin II can do a couple things, but one of those things is it increases aldosterone release from the adrenal gland,

228

and it also increases ADH release from the posterior pituitary.

229

Now, with all of this being said, what's the overall effect of all of this?

230

I'll show you.

231

Angiotensin II works on your vessels.

232

You got a lot of angiotensin II receptors on your vessels.

233

So here, let's say we have what's called a angiotensin II receptor here in your vessels.

234

Guess what it does?

235

Squeezes the heck out of them.

236

What'd that do?

237

SVR goes up, because that's the compensatory mechanism.

238

If SVR goes up, then what happens to your afterload?

239

That goes up.

240

What happens if you have diastolic heart failure?

241

You worsen the hypertrophy.

242

Patient's getting sicker, that's not helpful.

243

What happens if you do to the preload?

244

You're going to cause more blood to get returned to the actual heart.

245

Pre -level goes up.

246

But in a patient who has systolic heart failure, what is that going to do?

247

It's going to dilate their heart even more and worsen it.

248

So you guys get the concept here is that this is another potential problematic issue that can worsen the patient's heart failure.

249

And that's why we have drugs that we'll talk about a little bit later

250

that I'm going to kind of preemptively kind of covering here that this will help to treat.

251

Because we just don't want to have these high angiotensin II levels, the high sympathetic nervous system activity and just to complete this concept aldosterone

252

and adh will be higher

253

and you know what this does this increases your reabsorption now the patient's reabsorbing lots of sodium

254

and water and if you reabsorb sodium and water what is

255

that going to do it's going to cause the patient to retain a lot of this fluid

256

and they're going to start developing edema they'll have more preload

257

so the ventricles will have to dilate more but one of the problems

258

that you'll see here is they'll start developing a lot of edema because of this.

259

So this is the concept that I really, really want you guys to be able to understand here with this nasty disease process.

260

There's one more thing, which is actually super cool though.

261

So this system here is called the ranin -angiotensin -aldosterone system, right?

262

You know, whenever your heart, your cardiac output's really, really low, another really interesting thing that happens is,

263

is that your heart, whenever it's like really low cardiac output, the hearts actually kind of get filled with blood.

264

And so they can release this molecule in response to a lot of stretch.

265

So let's say that the heart is really, really, really being stretched.

266

It's being stretched a lot.

267

When the heart is being stretched a lot, it makes a molecule called atrial natriuretic peptide.

268

And it makes a lot of it.

269

And the whole point of increasing this atrial nectarine peptide is it wants to go and inhibit.

270

The hope is that it inhibits angiotensin 2.

271

And if I inhibit angiotensin 2, I prevent this whole disastrous process from occurring.

272

Well, that's cool.

273

I would really like drugs that increase AMP then.

274

I would really like drugs that decrease angiotensin 2, block aldosterone, and block the sympathetic nervous system.

275

And that's what we'll talk about in the treatment section.

276

But this is what I want you guys to understand about left heart failure.

277

Now let's quickly go through right heart failure and high output failure.

278

Bye my friends, so now we got to talk about right heart failure.

279

So we talked about the left heart failure.

280

The right heart failure is actually a lot easier.

281

When we talk about right heart failure, it's the same kind of concept.

282

We take this normal heart and we jack it up to cause systolic heart failure.

283

Now when we talk about this, it's again, you're dropping what?

284

The contractility.

285

So what generally drops contractility on that right heart?

286

Well, in the left heart, the most common cause was an mi guess what it would be here an mi okay

287

so generally a right ventricular mi is going to be the

288

most common cause generally of this systolic right heart failure

289

so you're dropping the contractility here

290

and that's leading to the formation of this systolic heart failure now again what you're going to notice is is

291

that this puppy's going to start beginning super dilated all right

292

so what you're going to notice is this dilated type of right ventricle.

293

Now, another concept here with this dilated right ventricle here is that your right ventricle,

294

the contractility is reduced, right?

295

So this whole right ventricle, let's say, is really, really messed up.

296

Because it's messed up, it's going to have a hard time being able to pump blood out into the pulmonary artery, right?

297

So it's going to have a hard time with forward flow.

298

so what you'll notice out of these patients is

299

that they are going to have a low right ventricular cardiac output right because of the contractility and

300

so because of

301

that they're going to have this low contractility

302

this is going to lead to a decrease in their right ventricular ejection fraction

303

now we don't generally give these you know as we compare prior

304

The heart failure with a reduced ejection fraction, that's primarily only consistent with left heart failure.

305

But again, you can think about it in this particular way.

306

But again, a reduction in contractility will lead to a reduction in the right ventricular ejection fraction.

307

And the problem is

308

that these patients are going to have a hard time generating a good cardiac output out of the right ventricle.

309

And so that's the concept here.

310

It's pretty straightforward.

311

Something is decreasing contractility because you infarct at the right ventricle.

312

In the other aspect over here, you have something increasing the afterload, right?

313

So if I have something increasing the afterload, in the example for left ventricle, it was hypertension, it was aortic stenosis.

314

For this one, it's anything that increases, I'm going to put a little parenthesis here, anything that increases the pulmonary vascular resistance.

315

So for the systemic circulation, it was called systemic vascular resistance that was hypertension or aortic stenosis and this thing it's anything that causes

316

pulmonary hypertension so we say this is pulmonary hypertension

317

and there is different types we'll talk about this in palm

318

when we go over pulmonary hypertension but there's type one

319

which is idiopathic type two

320

which is due to left heart failure type three due to some type of like lung disease like copd

321

or interstitial lung disease type four due to some type of chronic pulmonary emboli

322

and then type 5 is there's usually something like sarcoidosis like something compressing the pulmonary vasculature

323

but this is the concept i want

324

you to understand pulmonary hypertension for right heart failure systemic hypertension for left heart failure for

325

that diastolic type now what do you notice here about this right ventricle it's thick right

326

so they have some hypertrophy generally of that right ventricle so we could say right ventricular

327

hypertrophy and this is usually because

328

that ventricle is going to have to thicken to be able to accommodate the high pressure of the pulmonary vasculature.

329

That's the only way it can do it and so

330

because of that it's going to have a hard time being able to fill with blood.

331

So the problem with this situation here is the same concept.

332

They have a reduction in right ventricular filling which causes them to have a again a normal ejection fracture.

333

They don't have a problem with their ejection fraction

334

so they have a normal right ventricular ejection fraction

335

so again decreased filling process

336

but normal right ventricular ejection fraction that's the big kind of thing

337

that i want you guys to understand here

338

now again remember both of these are going to have a reduction in right ventricular cardiac output

339

it's just again the mechanism behind them developing this all right

340

that covers this one for right heart failure the pathophysiology and the causes.

341

What about this weird one?

342

There's this weird entity called high output heart failure and generally high output heart failure is particularly only consistent with generally left, so the left heart.

343

And what I want to do quickly is talk about this one.

344

So for the most part what you've noticed that

345

when we talked about left heart failure before is

346

that there was a low cardiac output and then when you talk about right heart failure there's a low cardiac output.

347

There's this weird entity in the world where this is called a high cardiac output heart failure.

348

You're like, what?

349

That seems odd.

350

It is weird.

351

But here's, let me, let me kind of explain why this happens.

352

And this patient here, we see that their vessels are super dilated.

353

So they have extremely super vasodilated blood vessels.

354

So what you'll notice here out of these patients is they have a massive vasodilation.

355

All right.

356

And when you vasodilate vessels that's a big thing we'll talk about what causes

357

but this is massive vasodilation all right

358

so there is massive vasodilation here the question

359

that you have to ask yourself is what's causing these vessels to become super super dilated

360

and there's a bunch of different things one reason

361

is very common is sepsis sepsis will cause massive vasodilation another one

362

which is an odd one is when you have thymine deficiency such as beriberi.

363

This will for some reason cause massive vasodilation.

364

Thyrotoxicosis, so when a patient has thyroid storm, this can also cause massive vasodilation.

365

Other kind of interesting things could be things like AV fistulas as well as severe, and I mean really, really severe, anemia.

366

These are particular things that in these diseases

367

but i would say sepsis being kind of one of the most common ones these will cause massive vasodilation

368

when you massively vasodilate these vessels

369

What happens to the systemic vascular resistance now?

370

Soccer's huge.

371

resistance has got to be low.

372

So now their systemic vascular resistance is crazy, crazy low.

373

Now, go back to that formula.

374

What was the formula called?

375

For everything with low output heart failure, we said that we have blood pressure is equal to cardiac output times systemic vascular resistance.

376

And all the ones that we talked about, cardiac output was low,

377

which dropped the blood pressure now in this disease process the systemic vascular resistance is low

378

which will cause the blood pressure to be low what has to compensate the cardiac output

379

and that's why we call this high output heart failure

380

so then what happens is

381

when your systemic vascular resistance drops what it does is it creates a reflex kind of situation

382

so what it does it'll drop the blood pressure

383

so the patient's blood pressure may drop when you drop the patient's blood pressure

384

What that's going to do is it's going to activate the sympathetic nervous system and the renin,

385

angiotensin, and aldosterone system, and that is going to increase the sympathetic nervous system.

386

Now, look at this.

387

If I increase the sympathetic nervous system, that's then going to go and work on the heart.

388

And when it goes and works on the heart, it's going to work on a bunch of different components here.

389

One is you have your SA node, your AV node, your bundles of Hiss and bundle branches.

390

That's all going to be activated.

391

And your heart rate is going to try to go up because it's going to hopefully try to increase your cardiac output.

392

And you're going to contract your heart like a son of a gun.

393

So then on top of that, you're going to try to cause the heart to really, really contract.

394

And the stroke volume will go up.

395

and both of these are going to be an attempt to

396

try to push as much blood possible out of the heart

397

so what you'll notice here is

398

that these patients will have a massive increase in their heart rate

399

and a massive increase in their stroke volume but here's what's really odd

400

you would think okay these guys are pumping

401

and i mean pumping blood out of their heart into the corner i mean into the systemic circulation

402

so the cardiac output has to be high enough right

403

it's got to be good enough to be able to meet the actual tissue demands it's not

404

and that's where the problem here in the cycle occurs

405

this disease causes vasodilation leads to this whole process tries to increase the cardiac output

406

but no matter what it's not enough to meet the body's demands

407

and so what happens here is it's not enough and that's the issue so you see how we talk about heart failure,

408

it's the inability to perfuse the tissues and meet their demands.

409

That would be a definition then.

410

So high output heart failure is the cardiac output's high,

411

but it's not high enough to overcome this massive vasodilatory effect to meet the tissue's oxygen demands, and that is heart failure.

412

So, so far we've gone over left heart failure, low output, right heart failure, low output, and the rarity of high output heart failure.

413

Now let's go over what are the complications of a patient developing heart failure.

414

Alright my friends, so now if a patient has left heart failure, whether that's diastolic or systolic heart failure,

415

or right heart failure, whether it's systolic or diastolic heart failure, we have to understand the particular complications that can arise.

416

When a patient has left heart failure, one of the big things that you'll see with these patients is features of pulmonary congestion.

417

So either way, the patient's cardiac output stinks.

418

They're not able to get enough blood out of their left ventricle.

419

So what happens is because they have a cardiac output that is being reduced, if you will, in other words,

420

in these patients, it's hard to get the blood out of the heart.

421

Because of why?

422

Because they have a reduced cardiac output.

423

Now, because of that, if the blood can't get out of the heart, where's it going to go?

424

It's going to start backing up into the left atrium

425

when it backs up into the left atrium

426

it goes into all of these like cute little pulmonary veins here see it starts moving into the pulmonary veins

427

and then what happens is it starts kind of like congesting these pulmonary veins intensely now

428

when the pulmonary veins start coming very very filled with all of this blood the pressure in those go up

429

and we specifically use a terminology here called pulmonary capillary wedge pressure so we use that on both of these here.

430

And this will go up.

431

And the pulmonary capillary wedge pressure is a measure of left heart pressures.

432

So if the left heart pressure is high, the pulmonary capillary wedge pressures will also be high.

433

When that happens, the pressure in the pulmonary capillaries rise enough that guess what starts leaking out of this actual vasculature?

434

Fluid.

435

So you're going to have fluid leaking out of this vasculature and into the interstitial spaces. and into the alveoli.

436

So now this alveoli is gonna become filled with fluid, you're gonna develop some edema here in the interstitial spaces,

437

and now these patients have pulmonary edema.

438

And so this is one of the potential complications is they get a little bit of pulmonary edema.

439

Now why is that bad?

440

When you have pulmonary edema, some patients can present a couple different ways.

441

One is they particularly present with what's called dyspnea.

442

Now dyspnea, it may just be a generalized dyspnea.

443

This may be with exertion.

444

This may be at rest.

445

That depends upon the severity of their CHF.

446

But another very interesting presentation is that whenever these patients lie flat,

447

the fluid tends to kind of separate out into multiple parts of the lungs.

448

Normally, they'll be in the dependent inferior portions.

449

But as you lay flat, this edema can become worse and spread throughout multiple alveoli

450

and this can worsen their actual shortness of breath when they're laying flat

451

and so there's two terminologies one is called paroxysmal nocturnal dyspnea this is whenever they're at their sleep

452

and they're laying flat they're super short of breath

453

or just in general maybe they're not sleeping they're laying down flat

454

or laying on a recliner

455

and they have some shortness of breath there it's the same concept

456

it's called orthopnea these are big big common features that we see with pulmonary edema.

457

One is just dyspnea, whether it be exertion or rest, or the other one is when they're laying flat, proxysmal nocturnal dyspnea or orthopnea.

458

Another potential problem here is that whenever these patients, let's say they really, really have a massive reduction.

459

So let's say that their cardiac output massively reduces, maybe for whatever reason.

460

Common triggers for patients to develop what's called acute decompensated heart failure is they have an MI

461

or they have a massive tachyarrhythmia or they stop taking their medications they're supposed to be taking.

462

And what this does is this massively drops the cardiac output, massively increases the pulmonary capillary wedge pressure, and worsens their pulmonary edema like terribly.

463

And sometimes this pulmonary edema can be severe.

464

I'm talking severe pulmonary edema and this is something

465

that we would generally see when a patient has what's called acute decompensated heart failure

466

and what happens is is this fluid will really start kind of leak like all over multiple different alveoli

467

and interstitial spaces will become filled with fluid

468

and this can cause a massive vq mismatch

469

when you fill up multiple alveoli with fluid

470

that causes a vq mismatch decrease in ventilation normal perfusion there's a mismatch and that leads to hypoxemia.

471

So watch out for a VQ mismatch here, and what will happen is the patient's SpO2 will be very low,

472

and they can exhibit features of what's called hypoxia.

473

The other thing is that this fluid that leaks into the interstitial spaces, when it actually does leak there,

474

sometimes it may just cause the patient to have generalized dyspnea or increased work of breathing.

475

So they may be working hard to breathe, or they may have a higher respiratory rate.

476

So that's another kind of thing

477

that you want to watch out for is watch out for an increased work of breathing or an increased respiratory rate.

478

So these are some of the big findings that you want to watch out for.

479

So again, watch out for a stimulation of VQ mismatch

480

because of all of these alveoli being filled with fluid and then hypoxia.

481

So watch their O2 sat to see if they have desaturations.

482

This is super, super common in left heart failure.

483

So big things to look out for is go to the patient, see if they have any respiratory distress or hypoxia on their O2 saturation,

484

ask them if you have any shortness of breath at rest, exertion, or when they're laying down flatter when they're sleeping.

485

The other thing, get your stethoscope that you paid

486

so much money for and go and listen and see if you hear any rails or crackles.

487

All of these are potential signs of pulmonary edema.

488

This is very common in left heart failure.

489

The scariest complication that I say that you would potentially see in a patient who has left heart failure is cardiogenic shock,

490

and this is definitely the scariest one.

491

Generally, again, a very common trigger here that can happen is an MI, a massive tachyarrhythmia, or you stop taking your medications.

492

These are very, very common triggers.

493

Now, again, same concept.

494

The patient has a massive drop in their cardiac output.

495

If you drop their cardiac output, you're not going to be getting enough blood flow out of their heart.

496

When you don't get enough blood flow out of the heart, particularly enough volume, you drop that cardiac output, what happens to their perfusion?

497

Oh, that's stinky.

498

That systemic perfusion goes down. So not only whenever

499

you have a low cardiac output do you have a hard time getting blood out of the heart

500

and it backs up into the lungs, but you have a a hard time getting it out of the heart and delivering it to multiple tissues.

501

When you have a decrease in systemic perfusion, The problem with this is that your body kind of says, okay, perfusion's kind of stinky right now.

502

That's because the cardiac output's really low.

503

You know what the body tries to do is it says, okay, what I'm going to do is if the cardiac output's low, what's that formula?

504

BP is equal to cardiac output times the systemic vascular resistance.

505

Let's write that out.

506

So BP is equal to cardiac output times the systemic vascular resistance.

507

And these patients who are in cardiogenic shock, this is low, causing this to be low.

508

What has to compensate my friends?

509

SVR.

510

And this will shoot through the roof.

511

And when SVR goes up, it clamps down on your vessels, squeezes them.

512

And now you have very little blood flow going to your extremities.

513

You know what this is going to do?

514

This is going to cause these patients to have very cold or pale extremities.

515

Another really, really terrifying sign here is they have like modeling, and this is really, really kind of scary.

516

It's where they have this weird kind of discoloration, usually at the knees, and that's a very sign of, that's a very poor sign of perfusion,

517

and this is usually because you're clamping down on those vessels to compensate.

518

Another thing is that when you have decreased systemic perfusion, not only do you create this reflexive vasoconstriction, but you also get organ malperfusion, right?

519

If I have organ malperfusion, oh man, that ain't good because now I'm not perfusing various tissues.

520

What are some of these tissues that actually become affected because of an increase in more organ malperfusion?

521

One is the brain.

522

The brain is super sensitive to blood pressure.

523

The coronary circulation, which supplies the myocardium of the heart, well, it's going to make things a lot worse.

524

It becomes very susceptible.

525

The kidneys become susceptible and the GIT would probably be the last one of the line, but it's also super susceptible.

526

If I don't perfuse the actual brain, then I can develop encephalopathy, and this is probably going to be one of the most common causes.

527

Sometimes, if the actual mouth perfusion is severe enough, it's possible it could cause a TIA slash CVA, all right?

528

So that's another thing you want to watch out for.

529

The other thing is that if you don't perfuse the actual myocardium well enough, it may cause a myocardial infarction.

530

So you may see things like an N -STEMI or a STEMI potentially.

531

So these are things that I think are really, really important to remember.

532

The other thing is it may stimulate, son of a gun, it may stimulate injury to the kidneys.

533

This is called an AKI.

534

There is a very common terminology that you may hear here.

535

When patients have very severe left heart failure and they don't perfuse their kidneys very well because of decreased systemic perfusion,

536

but also their CVPs are really high, so it's hard to get blood out of the kidney.

537

They can develop something called cardiorenal syndrome.

538

Very common trigger of AKI, so don't forget that one.

539

And the last one is they may cause acute mesenteric ischemia.

540

This is another really, really big one, or ischemic colitis.

541

And this is another big trigger, so you're going to want to watch out for any kind of like bowel ischemia and abdominal pain.

542

The last thing that's always a feature of systemic perfusion

543

that's being very very poor is your tissues whenever there's very little oxygen that's being delivered to the tissues

544

so here this tissue is supposed to be getting oxygen

545

if it's getting very very little oxygen they do not like that

546

and what they do is they trigger the production of a molecule

547

that's usually a sign of poor perfusion you guys know what that's called lactic acid

548

but lactic acid gets broken down into lactate and

549

so you want to watch out for this because one of the things

550

that this will do is this will really cause the pH to drop and it'll trigger an acidosis.

551

So watch out for acidosis that can occur in the setting of cardiogenic shock.

552

So again, when a patient has heart failure, it can kind of look a little bit different.

553

The patient may have chronic CHF or their primary symptom may just be dyspnea, paroxysmal nocturnal dyspnea, or orthopnea.

554

But if they develop an acute decompensated heart failure from those triggers, MI, tachyarrhythmias, medication, non -compliance,

555

they can develop severe pulmonary edema, hypoxia, respiratory distress.

556

And most patients who have chronic CHF, they may just have minimal decreased systemic perfusion.

557

And the way that they compensate is an increase in systemic vascular resistance.

558

So they may have cold, kind of pale mottled extremities.

559

But whenever it's really bad, to where there is an acute decompensated heart failure due to an MI,

560

tachyarrhythmias, medication non -compliance, now they don't perfuse multiple organs.

561

And they can develop things like encephalopathy, MI, AKI, and acute mesenteric ischemia, and lactic acidosis.

562

These are big things to think about, my friends.

563

All right, we come to the last one here.

564

Patient has right heart failure, all right?

565

So if the patient has a right heart failure, it's because they had something wrong with the contractility or the high afterlope, pulmonary hypertension.

566

This one's super easy, thank goodness this.

567

Whenever the right heart is damaged, what happens is again the whole concept here is

568

that it's either you can't fill it

569

or you can't get blood out of it right

570

so that's either one of those concepts you can't get blood in

571

or you can't get blood out of it when

572

that happens what happens is the pressure in the right heart increases

573

and we use a terminology to really describe that

574

and that's called your central venous pressure so your central venous pressure becomes very high when your central venous pressure is high,

575

what happens is the blood is kind of a measure of the blood backing up into your superior vena cava

576

and blood backing up into your inferior vena cava.

577

And what this will do is this will kind of present in two different ways

578

that you want to try to look for.

579

One is it'll present with a patient having a lot of jugular venous distension.

580

So they'll have a plump jugular vein.

581

And the other one is they'll have some edema of their lower extremities, usually what's called pitting edema.

582

So when you press on it, it kind of really dips in and gives this kind of deformity there.

583

This is super common in right heart failure.

584

Another common presentation, again, regardless of the type, whether it's problem filling or problem getting out,

585

the concept is the same is that you have a very high central venous pressure

586

when your central venous pressure is high the blood is going to back up into the inferior vena cava

587

and what it does is it causes one particular problem

588

which leads to hepatic congestion

589

so you know the liver

590

I'm kind of zooming in on a basic model of the liver let's say

591

this is a liver cell this is an artery this is the hepatic veins

592

which empty into the IVC and this is a biliary duct.

593

Whenever this hepatic vein is congested and it can't get blood to go up,

594

it congests in the liver and causes the liver to become injured and damaged.

595

And you know what this could potentially present as?

596

This could cause a patient to develop liver failure.

597

More specifically, I would say you see this more commonly as a cirrhotic kind of presentation

598

but you can see this as a potential trigger of liver failure

599

because of the increased hepatic congestion all right the other thing

600

that it can do is it can increase your portal pressure

601

so what happens is your hepatic veins what happens is it can actually cause

602

this to really cause the portal pressure within the venous circulation the hepatic portal circulation to become very very high

603

so if you increase your portal pressure

604

what this does is this causes the hydrostatic pressure in the portal veins

605

and the peritoneal capillaries to be super high and leak fluid into the abdomen.

606

And when you leak this fluid into the abdomen, what do we call this type of fluid that leaks into the abdomen?

607

Ascites.

608

And so that's another very, very common presentation here is ascites.

609

So watch out if a patient develops liver failure and they have a history of right heart failure, think about that.

610

If they have ascites and they have a history of right heart failure, think about that.

611

And again, if they have very plump jugular veins and pitting edema, think about a right heart failure.

612

And the last one, it's not commonly thought of, but it can happen.

613

Left heart failure, we talked about cardiogenic shock.

614

Right heart failure can also get cardiogenic shock.

615

So think about this.

616

This concept is super interesting.

617

In this situation here, you're having, let's say, blood difficulty.

618

This is more common in the systolic types,

619

where the vent right ventricle super dilated in this situation you have problem getting blood out of the right heart

620

and because of that now this right ventricle has a hard time

621

if it becomes super dilated maybe it can't fill properly

622

or it just can't get blood out of the heart when

623

that happens because you can't get blood out of the heart the right ventricle dilates even more

624

so if it's dilated before it dilates more all right

625

so now this sucker is huge

626

so whenever this happens you can't get blood out of the heart

627

it's going to stimulate the right ventricle to dilate even more

628

when the right ventricle dilates more the next thing

629

it does is is it causes the septum to bow over into the left ventricle

630

and now look at the space of the left ventricle it's smaller

631

so then it causes it's called a septal shift

632

so a septal shift and we'll say

633

that this septal shift is occurring from right to left from the right side to the left side what

634

that does is is it makes it hard for the left ventricle to fill with blood because now it's much smaller

635

if it can't fill with blood what happens to the left ventricular cardiac output it drops.

636

So now you have a septal shift and that's going to cause a decrease in the left ventricular filling.

637

If you decrease the left ventricular filling, that is going to then do what?

638

That is going to decrease the left ventricular cardiac output.

639

And if you decrease the left ventricular cardiac output, that can potentially lead to systemic malperfusion.

640

And then if we go on further, cardiogenic shock.

641

So this is a pretty scary one.

642

I'm actually usually, we don't see this one too often, right heart failure causing cardiogenic shock.

643

But when you do, it's pretty terrifying because it's a really, really bad one.

644

But this is another potential one that I want you to think about,

645

but you really primarily only see this one with right ventricular MI as the particular etiology here.

646

Not so much the pulmonary hypertension causes.

647

All right, my friends, that covers the issues or complications, if you will, of heart failure.

648

It's a pretty disastrous thing if it gets really, really bad.

649

What I want to do now is I want to take you through how to diagnose heart failure.

650

First thing is get a chest x -ray.

651

This will help you because if they have cardiomegaly, that's somewhat helpful.

652

Do they have pleural effusions, pulmonary edema, and curly B lines?

653

That's all suggestive of left heart failure for the most part.

654

Now, with that being said, if a patient has these findings, that doesn't define or determine that they have heart failure.

655

I want to combine, oh, they have pulmonary edema, pleural effusions.

656

Is their left heart not doing a good job?

657

Well, one way I could say if their heart is not doing a good job is they could check BMP.

658

This is not a good test though.

659

It's usually used in the emergency department to kind of quickly exclude a CHF exacerbation because if BMP levels are really low,

660

then you can say, okay, their dyspnea is probably not from a CHF exacerbation.

661

If it is really high, then you can't rule that out.

662

The better test is an echocardiogram because it's going to look directly at the heart and it's going to look to say,

663

hey, what's their ejection fraction?

664

Is it less than 40 %?

665

Their left ventricle doesn't look like it's moving at all.

666

That's systolic heart failure.

667

Or does it look like the left ventricle is contracting and pumping, but it's not filling properly.

668

Oh, that's diastolic heart failure.

669

In combination with a chest x -ray, that can be very beneficial.

670

Also do your physical exam.

671

If you don't see anything on the chest x -ray, look at the JVD, look at the legs,

672

look at the abdomen to look to see if they have any features of systemic congestion and combine that with their echo.

673

After you've done that, you should be able to determine is it right versus left.

674

That's pretty straightforward.

675

Now, the most definitively diagnostic test to determine

676

if the patient is an acute left heart failure

677

or in left heart failure in general is to do a

678

right heart catheterization also referred to as a swan gons catheter

679

you take a catheter you run it down the ij

680

you run it into the pulmonary into the right atrium into the pulmonary artery

681

and up into these like pulmonary artery capillary areas inflate the balloon

682

and then measure the pressures i told you

683

that the pulmonary capillary wedge pressure if it's really high that's very suggestive of a failure of the left heart

684

And if it's greater than 18 millimeters of mercury, that's a very suggestive number of left heart failure.

685

So if a patient has elevated BMP levels and echo

686

and a pulmonary capillary wedge pressure greater than 18 in combination with a chest x -ray suggestive of pulmonary edema,

687

I can really be confident in them having left heart failure.

688

Now, with that being said, if a patient has acute left heart failure, it's important to go through their medication list

689

and look to see what their heart rate is and look to see if they have any valvular disturbances.

690

But one of the big ones that I have to do is get an EKG

691

and also consider a left heart cath if I think they're having an MI

692

because that's going to find the occlusion and then treat that.

693

And that might be the thing that knocks them out of this acute heart failure potentially.

694

All right.

695

How do we treat heart failure?

696

This is a really, really important topic.

697

When I treat them, I specifically went into this for a reason.

698

I want to reduce sympathetic nervous system activity, reduce RAS activity and increase AMP activity.

699

And if you remember increasing AMP activity did what decrease RAS.

700

So my goal is to decrease sympathetic, decrease sympathetic, and decrease RAS.

701

How do I do that?

702

Well, if I decrease my sympathetic nervous system, I have to use things like beta blockers and SGLT2 inhibitors.

703

So metoprolol, carvetolol, or impagiflozin.

704

Usually these SGLT2 inhibitors are very, very important in patients with diabetes, but if they have cardiovascular disease, it's also beneficial.

705

And what happens is they reduce the sympathetic nervous system.

706

That reduces the heart rate, and that also reduces the systemic vascular resistance.

707

I don't constrict the veins.

708

I don't constrict the arteries as much.

709

I don't reduce, uh, I don't actually cause changes in preload and afterload, and I don't cause ventricular remodeling that improves ventricular function.

710

That's mortality beneficial right there.

711

The other thing is that SGLT2 inhibitors also cause aqua uresis.

712

They cause you to pee out of tons of water.

713

And so that can help with a lot of the edema of the patient is edematous.

714

The next concept is I want to reduce a RAS activity.

715

So the reason why is whenever low cardiac output.

716

Again, we said increased sympathetic and low cardiac output activate renin.

717

So renin leads to eventually angiotensin 2.

718

But if I give them a drug called an ACE inhibitor that blocks angiotensin 1 from being converted into angiotensin 2.

719

If I also give them a drug like an ARNI that increases AMP, it prevents AMP from being degraded.

720

If AMP builds up, it shuts down angiotensin too.

721

And then if I also give an ARB, ARB blocks angiotensin 2 from binding to receptors.

722

All three of these drugs will help to decrease angiotensin 2.

723

If I decrease angiotensin 2, I reduce the constrictions of the arteries in the veins and I reduce ventricular remodeling and that's a mortality benefit.

724

Another thing is angiotensin 2, if there's less of it, there's less aldosterone and also ADH,

725

but particularly aldosterone because now there's less sodium and water retention.

726

If I don't retain as much sodium and water, I don't have as much edema, but I also don't have as much preload

727

and i don't cause ventricular remodeling

728

that's where aldosterone antagonists would be really really beneficial in shutting down aldosterone production this is the concept

729

and these are the drugs that we have to incorporate in patients who have heart failure

730

because they have mortality reducing benefits okay that's a part of our guideline directed medical therapy other things

731

that we can add on with guideline directed medical therapy is alternatives

732

so if a patient's african -american they can't tolerate an ace inhibitor and arb

733

hydralazine and isosorbidinitrate is a good combo to add because they're good vasodilators.

734

The other one is an alternative to a beta blocker.

735

If they're maxed on a beta blocker and they are in normal sinus rhythm, ivebrating can be considered.

736

If you want to help them to get rid of a lot of the sodium and water retention,

737

you can make them pee it out by giving them diuretics, loop diuretics and thiazide diuretics.

738

And then the next thing is if a patient has the need for device therapy.

739

So what I mean by this is if a patient has heart failure, especially left heart failure.

740

It stretches out the left ventricle and kind of causes left bundle branch blocks.

741

And then that alters the synchrony of the ventricles.

742

If I give them what's called a CRT, cardiac resynchronization therapy, it'll make sure that the ventricles are contracting kind of in tandem

743

and improve potentially the left ventricular ejection fraction.

744

I should definitely be instituting that in patients with an LVEF less than 35 % and an LVB.

745

All right.

746

That's a CRT.

747

If a patient has a left ventricular ejection fraction less than 35 % and they have ventricular arrhythmias, they need to get an AICD.

748

This will shock them if they go into VTAC or into VFib and prevent them from going into cardiac arrest.

749

The next thing is if a patient is on all of these medications, they have device therapy, their left ventricular ejection fraction is less than 25%,

750

they're not looking good and they look like they're going to need a transplant, sometimes we will play something called an LVAD,

751

a left ventricular assist device, which will take blood from their left ventricle

752

and shunted a different direction into the order to give that left ventricle some time to rest

753

now

754

and patients who are in cardiogenic shock all right their systemic perfusion stinks i want to have one primary goal

755

which is to increase systemic perfusion

756

so increasing systemic perfusion is very beneficial in patients who are in cardiogenic shock so what could i do

757

inotropes or mechanical circulatory support.

758

One way I can do that is I can give them things like dobutamine or milrinone.

759

These are commonly used in acute decompensated heart failure or cardiogenic shock.

760

The benefit of these is that they reduce afterload and increase contractility, which combined increased cardiac output.

761

The downside is that evidence has shown no reduction in mortality.

762

The other drug is digoxin.

763

This is an oral and IV drug.

764

So you can take this out outpatient, you can't take these outpatient.

765

This you can give to the patient and it's been shown to increase contractility and decrease AV node conduction.

766

So it's good in atrial fibrillation as well.

767

It is not shown to reduce mortality, but it may reduce the actual hospitalizations.

768

So there's a potential benefit to digoxin and increasing perfusion, especially in patients with cardiogenic shock, and even as an outpatient continuing that drug.

769

If the patient is failing these inotropes and they're continuing to decompensate and showing signs of potential failure, then we go to device therapy.

770

And there's two ways that we could go here.

771

An intraordial balloon pump has been shown to at least preserve coronary perfusion.

772

So this sucker deflates during systole to get blood to go forward.

773

And then it actually inflates during diastole.

774

So here during diastole, it inflates and it keeps the pressure all here in the aorta really high.

775

And what that does is guess what comes right off of the aorta here, the coronary arteries.

776

So if the pressure is high in the aorta during diastole, it's going to improve coronary perfusion and improve myocardial contractility.

777

And that's the benefit of this.

778

Most times, patients who'd end up on cardiogenic shock refractory to a lot of medications,

779

such as dobitamine, milrinone, introverted balloon pumps may require something called VA ECMO.

780

This is called venal arterial extracorporeal membrane oxygenation.

781

We take a catheter, we run it into one of their veins, we run it out of the vein and into a pump.

782

From there, we run it through an oxygenator, and then we put it in a catheter that runs right into their artery.

783

These are big stinking catheters, and they are designed to be able to help to maintain a decent amount of flow

784

and augment the cardiac output and also oxygenate the blood.

785

So this is a potential beneficial therapy that could be used as a patient in refractory cardiogenic shock.

786

The other thing I think that's important to remember in a patient who's in cardiogenic shock

787

or having any signs of cardiogenic pulmonary edema.

788

is what's called BiPAP.

789

Using diuretics to help to get rid of some of the sodium and water, which will help to reduce some of that actual pulmonary edema,

790

but BiPAP has been shown to potentially increase the antithoracic pressure, and that will help to reduce right ventricular prelip.

791

So you don't have as much blood going to the right heart, and you don't have as much blood going out of the right heart.

792

So now less blood is going through the pulmonary circulation and going to the left heart.

793

If there's less blood going that way, that's going to have less blood leaking out into the pulmonary interstitium, less pulmonary edema.

794

The other concept is it drops your left ventricular afterload.

795

So the pressure in the aorta drops.

796

So it's easier to get blood out of the left ventricle into the aorta.

797

So you have less blood coming to the left heart and you have more blood going out of the left heart.

798

That's going to improve your cardiac output and reduce pulmonary edema, but more particularly reduce pulmonary edema.

799

And that's one of the benefits of this drug in patients who are in acute heart failure or potentially cardiogenic shock.

800

All right.

801

I know this is a lot.

802

Let's go through this in a systematic approach.

803

A patient comes in, they have heart failure.

804

You've changed their modifiable risk factors.

805

After that, you start them on an ACE inhibitor, an ARB, all right?

806

Plus a beta blocker.

807

They're still symptomatic.

808

Give them diuretics to reduce venous congestion, whether it's systemic or pulmonary.

809

They're still symptomatic.

810

Add on aldosterone antagonists and an SGLT2 inhibitor.

811

They're still symptomatic, and they're potentially unable to tolerate an ACE inhibitor or an ARB.

812

Well, switch them.

813

Switch to an ARNI if possible, so an angiotensin receptor neprolysin inhibitor.

814

So this would be things where you put them on, like, Secubitril, Valzartan.

815

So these are very good drugs that have been shown to be very beneficial.

816

The other thing is if they can't do that one, or if they're African -American, consider Hydralazine and Isosorbidinitrate it actually has a mortality benefit.

817

If the patients are symptomatic on all these therapies and a normal sinus rhythm maxed out on a beta blocker, give them ivabraiding.

818

If the patient has a left ventricular ejection fraction less than 35 %

819

and a left bundle branch block or a QRS greater than 120, give them cardiac resynchronization therapy.

820

If despite all of these measures, they remain symptomatic, try to increase their perfusion.

821

Usually inotropes would be the next step here.

822

So digoxin would probably be the one that you'd want to continue outpatient if they're in overt cardiogenic shock, melrenone or dobutamine.

823

And then from there, if you have to mechanical circulatory support, if they're in overt cardiogenic shock, intriotic balloon pumps, VA ECMO, hopefully they recover.

824

And then the thing that you would need to put them on to bridge them to a transplant is an LVAD.

825

And hopefully they would get a cardiac transplant and improve.

826

all right my friends that covers heart failure i hope it made sense i hope

827

that you guys enjoyed it and as always until next time

تنزيل التطبيق

كل ما تحتاجه للتحدث بطلاقة

تقييم النطق بالذكاء الاصطناعيتقييم كل جملة

تدريب IPAأتقن كل صوت

المفرداتابنِ رصيدك من الكلمات

لعبة المفرداتتعلّم أثناء اللعب

امسح رمز QR

Download on theApp Store Get it onGoogle Play

نفس القناة

المفردات وملاحظات التحدث لهذا الدرس

هذا الدرس في المحادثة مبني على الفيديو “Congestive Heart Failure”. أكثر الكلمات تكرارًا في الفيديو: failure, patient, blood, output, cardiac. يحتوي هذا الفيديو على 827 جملة و10365 كلمة للتدرب على الترديد. مدة الكلام 57:53. يتكلم المتحدث بسرعة طبيعية، نحو 179 كلمة في الدقيقة، قريبة من المحادثة اليومية. 80% فقط من الكلمات ضمن أكثر 3,000 كلمة شيوعًا في الإنجليزية، فالمفردات صعبة نسبيًا.

أهم المفردات في هذا الفيديو

15 كلمة من الفيديو تستحق التعلّم، مع النطق والمعنى:

الكلمة	النطق	المعنى
output اسم	/ˈaʊtpʊt/	مُخرَج
cardiac صفة	/ˈkɑɹdiˌæk/	قَلْبِيّ
systemic صفة	/sɪˈstɛm.ɪk/	نِظَامِيّ
fraction اسم	/ˈfɹæk.ʃən/	قِطْعَة
shock اسم	/ʃɔk/	صَدْمَة
vein اسم	/veɪn/	وَرِيد, عِرْق
fluid اسم	/ˈflu.ɪd/	سَائِل, مَائِع
vessel اسم	/ˈvɛsəl/	فُلْك
pump اسم	/pʌmp/	مِضَخَّة
trigger اسم	/ˈtɹɪɡɚ/	زِنَاد
artery اسم	/ˈɑɹ.təɹ.i/	شِرْيَان
tissue اسم	/ˈtɪʃ.(j)u/	مَنْدِيل, مِنْدِيل
leak اسم	/liːk/	تَسَرُّب
receptor اسم	/ɹɪˈsɛp.tə/	مُسْتَقْبِل
reduction اسم	/ɹɪˈdʌk.ʃən/	نَقْص

الأفعال المركبة التي ستسمعها

الكلمة	المعنى
go up فعل	صَعِدَ, يَصْعَدُ
go down فعل	نَزَلَ
knock down فعل	صَرَعَ

جمل تستحق التكرار

جمل قصيرة وكاملة من الفيديو يمكنك استخدامها في الحديث اليومي:

Do you lose contractility there?
Do you guys know why?
Do you guys remember the formula for blood pressure?
What happens if you have diastolic heart failure?
What happens if you do to the preload?

القواعد في هذا الفيديو

أكثر التراكيب التي يستخدمها المتحدث، مع العبارات نفسها من الفيديو:

التركيب	في الفيديو
المضارع التام have/has + اسم المفعول — حدث ماضٍ ما زال له أثر الآن	you've noticed · we've gone · has left
المبني للمجهول be + اسم المفعول — التركيز على ما يحدث لا على من يفعله	is damaged · is knocked · would be called
جمل الوصل who / which + جملة — معلومة إضافية عن شخص أو شيء	person who has · fraction, which is · HEFREF, which is
الاحتمال بـ “might / may” might/may + فعل — شيء ممكن لكنه غير مؤكد	may be · may drop · may just be

نطق يحتاج إلى انتباه

يستخدم المتحدث 159 من الصيغ المختصرة، مثل they're, you're, don't. انطقها بصيغتها القصيرة كما تسمعها.

أصوات “th”: sympathetic /ˌsɪm.pəˈθɛt.ɪk/, thick /θɪk/, breathe /bɹiːð/, rhythm /ˈɹɪð.əm/, catheter /ˈkæθɪtɚ/
أصوات “sh” و“zh”: fraction /ˈfɹæk.ʃən/, shock /ʃɔk/, potentially /pəˈtɛnʃ(ə)li/, tissue /ˈtɪʃ.(j)u/, reduction /ɹɪˈdʌk.ʃən/
الكلمات الطويلة — انتبه لموضع النبر: sympathetic /ˌsɪm.pəˈθɛt.ɪk/, potentially /pəˈtɛnʃ(ə)li/, medication /mɛdɪˈkeɪʃən/, beneficial /ˌbɛn.ɪˈfɪʃ.əl/, circulation /ˌsɝkjʊˈleɪʃən/

أصوات يجدها متحدثو العربية صعبة:

/p/ — ليس /b/: انطقه مع نفخة هواء: output /ˈaʊtpʊt/, sympathetic /ˌsɪm.pəˈθɛt.ɪk/, pump /pʌmp/, potentially /pəˈtɛnʃ(ə)li/, receptor /ɹɪˈsɛp.tə/
/v/ — ليس /f/: مع اهتزاز الأوتار الصوتية: vein /veɪn/, vascular /ˈvæskjələ/, vessel /ˈvɛsəl/, preserve /pɹəˈzɝv/, valve /ˈvælv/
تتابع الصوامت — لا تضف حركة بينها: fraction /ˈfɹæk.ʃən/, fluid /ˈflu.ɪd/, vascular /ˈvæskjələ/, pump /pʌmp/, trigger /ˈtɹɪɡɚ/

كيف تتدرب بهذا الفيديو

استمع إلى الفيديو كاملًا مرة واحدة دون أن تتكلم، ودوّن الكلمات التي لا تعرفها.
ابدأ بسرعة 0.75×، وردّد جملة جملة، ثم عُد إلى السرعة العادية عندما يصبح الأمر سهلًا.
سجّل صوتك وقارنه بالأصل، مع الانتباه إلى كلمات مثل output, cardiac, systemic.

ما هي تقنية التظليل الصوتي؟

التظليل الصوتي (Shadowing) تقنية تعلم لغة مدعومة علمياً، طُورت أصلاً لتدريب المترجمين الفوريين المحترفين. الطريقة بسيطة لكنها قوية: تستمع لصوت إنجليزي أصلي وتكرره فوراً بصوت عالٍ — كظل يتبع المتحدث بتأخير 1-2 ثانية. تُظهر الأبحاث تحسناً كبيراً في دقة النطق والتنغيم والإيقاع وربط الأصوات والاستماع والطلاقة.

تقنية الشادوينغ: اقرأ الدليل الكامل خطوة بخطوة →

تدريب Shadowing: Congestive Heart Failure | Clinical Medicine - تعلم التحدث بالإنجليزية عبر الفيديو

اختر وضع التدريب

تنزيل التطبيق

Antimycobacterials | Anti-TB Drugs

Metabolism | Electron Transport Chain: DETAILED | Part 1

Cell Biology | Cell Structure & Function

Homeostasis

Antibiotics: Cell Wall Synthesis Inhibitors: Part 1

Neurology | Facial Nerve: Cranial Nerve VII

Anatomy of the Heart and Coronary Circulation

Pharmacokinetics | Drug Absorption

المفردات وملاحظات التحدث لهذا الدرس

أهم المفردات في هذا الفيديو

الأفعال المركبة التي ستسمعها

جمل تستحق التكرار

القواعد في هذا الفيديو

نطق يحتاج إلى انتباه

كيف تتدرب بهذا الفيديو

ما هي تقنية التظليل الصوتي؟